Celebrating 10 Years of Trusted News Discovery
One News Page
> >

GlaxoSmithKline Will Split Into 2

Video Credit: Wochit - Duration: 00:46s - Published < > Embed
GlaxoSmithKline Will Split Into 2

GlaxoSmithKline Will Split Into 2

LONDON (Reuters) - GlaxoSmithKline plans to split into two businesses — one for prescription drugs and vaccines, the other for over-the-counter products — after forming a new joint venture with Pfizer’s consumer health division.

The logo of U.S. pharmaceutical corporation Pfizer Inc.

Is seen at a branch in Zurich, Switzerland October 2, 2018.

REUTERS/Arnd Wiegmann The revamp is the boldest move yet by GSK Chief Executive Emma Walmsley, who took over last year.


Recent related news from verified sources

Mylan launches Advair generic at one-third price

Mylan NV on Tuesday priced its generic version of GlaxoSmithKline's blockbuster asthma treatment...
Reuters - Published

GSK Consumer Healthcare's Q3 net profit up 35%

GlaxoSmithKline (GSK) Consumer Healthcare on Thursday reported a 35.07 per cent rise in net profit...
Sify - Published

Bharat Biotech to acquire rabies vaccine maker Chiron Behring

Bharat Biotech on Friday announced that it has signed an agreement with GlaxoSmithKline Asia to...
Sify - Published

You Might Like

Recent related videos from verified sources

GSK looks to new chapter [Video]GSK looks to new chapter

► Subscribe to the Financial Times on YouTube: FT pharmaceuticals correspondent Andrew Ward and Lex editor Robert Armstrong discuss whether GlaxoSmithKline can ease..

Credit: Financial Times     Duration: 03:40Published

Novartis/GSK -- expensive restructuring? [Video]Novartis/GSK -- expensive restructuring?

GlaxoSmithKline has struck a three-way agreement worth $16bn with Novartis to reorganise their businesses. Lex's Joseph Cotterill and Robert Armstrong discuss whether the reorganisation aids a prime..

Credit: Financial Times     Duration: 02:52Published

GSK in China - where now? [Video]GSK in China - where now?

► Subscribe to the Financial Times on YouTube: GlaxoSmithKline must pay the largest corporate fine ever levied in China after its subsidiary there was found guilty of..

Credit: Financial Times     Duration: 03:25Published

GSK's challenging year | FT Business [Video]GSK's challenging year | FT Business

► Subscribe to the Financial Times on YouTube: Sir Andrew Witty, chief executive of GlaxoSmithKline, talks to the FT's pharmaceuticals correspondent Andrew Ward about a..

Credit: Financial Times     Duration: 04:35Published

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Contact us  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest